Investor List:

Top BioTech Series B Investors in Canada (17)

Know someone who's actively diligencing and investing? Add them to this list.
About this list
We’ve compiled a list of the top BioTech investors. The goal is to help Founders find the best investors to target and get introduced to.
Photo of James C. Murray, Partner at ExSight Capital Management
James C. Murray
Sweet spot: $1M
Range: $200K - $4.0M
Investors in Europe, Investors in Canada, Investors in United States
Investors in Medical Devices (Seed), Investors in Hardware (Seed), Investors in Robotics (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series B), Investors in Hardware (Series B), Investors in Hardware (Series A), Investors in Medical Devices (Series B), Investors in Medical Devices (Series A), Investors in BioTech (Seed), Investors in Robotics (Series A), Investors in Robotics (Series B), Investors in Pharmaceuticals (Series B), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in Investors who were founders (Other Lists), Investors in Health & Hospital Services (Series B), Investors in Investors who invested in female founders (Other Lists), Investors in BioTech (Seed), Investors in Investors who invested in diverse founders (Other Lists), Investors in Hardware (Seed), Investors in New York City (Other Lists), Investors in Health & Hospital Services (Series A), Investors in Medical Devices (Seed), Investors in Robotics (Seed), Investors in Pharmaceuticals (Seed), Investors in Health & Hospital Services (Seed), Investors in BioTech (Series A), Investors in Hardware (Series A), Investors in Medical Devices (Series A), Investors in Robotics (Series A), Investors in Health & Hospital Services (Series A), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series B), Investors in Hardware (Series B), Investors in Medical Devices (Series B), Investors in Robotics (Series B), Investors in Health & Hospital Services (Series B), Investors in Pharmaceuticals (Series B), Investors in Canada (Other Lists), Investors in Drug Delivery (Series A), Investors in Diagnostics (Seed), Investors in Digital Health (Seed), Investors in Digital Health (Series B), Investors in Digital Health (Series A), Investors in Diagnostics (Series B), Investors in Diagnostics (Series A), Investors in Diagnostics (Seed), Investors in Drug Delivery (Series B), Investors in Diagnostics (Series B), Investors in Diagnostics (Series A), Investors in Drug Delivery (Seed), Investors in Drug Delivery (Series A), Investors in Drug Delivery (Series B), Investors in Drug Delivery (Seed), Investors in Digital Health (Series B), Investors in Hardware (Pre-seed), Investors in Medical Devices (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Drug Delivery (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in Robotics (Pre-seed), Investors in Digital Health (Pre-seed), Investors in BioTech (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in Hardware (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Robotics (Pre-seed), Investors in Medical Devices (Pre-seed), Investors in Digital Health (Pre-seed), Investors in Therapeutics (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in BioTech (Pre-seed), Investors in Drug Delivery (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in Therapeutics (Series A), Investors in Therapeutics (Series A), Investors in Therapeutics (Seed), Investors in Therapeutics (Series B), Investors in Therapeutics (Seed), Investors in Therapeutics (Pre-seed), Investors in Therapeutics (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed)
Photo of Terrence Rohan, Managing Director at Otherwise Fund
Terrence Rohan
Otherwise Fund·Managing Director
Sweet spot: $500K
Range: $100K - $1M
Investors in Canada, Investors in United States, Investors in San Francisco (CA)
Investors in Web3/Blockchain (Series B), Investors in Web3/Crypto (Series B), Investors in BioTech (Series B), Investors in Consumer Internet (Series B), Investors in Web3/Blockchain (Seed), Investors in Marketplaces (Series B), Investors in Web3/Blockchain (Series A), Investors in BioTech (Seed), Investors in Web3/Crypto (Series A), Investors in BioTech (Series A), Investors in Marketplaces (Series A), Investors in SaaS (Series B), Investors in BioTech (Seed), Investors in Web3/Crypto (Seed), Investors in Web3/Blockchain (Seed), Investors in Consumer Internet (Seed), Investors in Web3/Crypto (Seed), Investors in Web3/Blockchain (Seed), Investors in BioTech (Seed), Investors in Consumer Internet (Seed), Investors in Web3/Crypto (Seed), Investors in Marketplaces (Seed), Investors in Consumer Internet (Seed), Investors in SaaS (Seed), Investors in Marketplaces (Seed), Investors in SaaS (Seed), Investors in BioTech (Series A), Investors in Web3/Blockchain (Series A), Investors in San Francisco Bay Area (Other Lists), Investors in Consumer Internet (Series A), Investors in Web3/Crypto (Series A), Investors in BioTech (Series A), Investors in Web3/Blockchain (Series A), Investors in Consumer Internet (Series A), Investors in Web3/Crypto (Series A), Investors in Marketplaces (Series A), Investors in SaaS (Series A), Investors in Marketplaces (Series A), Investors in BioTech (Series B), Investors in SaaS (Series A), Investors in Web3/Blockchain (Series B), Investors in Web3/Crypto (Series B), Investors in Consumer Internet (Series B), Investors in BioTech (Series B), Investors in Web3/Blockchain (Series B), Investors in Marketplaces (Series B), Investors in Consumer Internet (Series B), Investors in Web3/Crypto (Series B), Investors in SaaS (Series B), Investors in Marketplaces (Series B), Investors in SaaS (Series B), Investors in Canada (Other Lists), Investors in Angel, Scout, and Solo-Capitalists (Other Lists), Investors in Generative Tech/AI (Seed), Investors in Generative Tech/AI (Series B), Investors in Generative Tech/AI (Series B), Investors in Generative Tech/AI (Series A), Investors in Generative Tech/AI (Series B), Investors in Generative Tech/AI (Series A), Investors in Generative Tech/AI (Seed), Investors in Generative Tech/AI (Seed), Investors in Generative Tech/AI (Series A), Investors in SaaS (Series A), Investors in Consumer Internet (Series A), Investors in Marketplaces (Seed), Investors in SaaS (Seed)
Photo of robert giles, Managing Director at CE VENTURE CAPITAL
robert giles
CE VENTURE CAPITAL·Managing Director
Sweet spot: $750K
Range: $250K - $5.0M
Investors in San Diego (CA), Investors in Austin (TX), Investors in New York (NY), Investors in Mexico (Mexico), Investors in Europe, Investors in Canada, Investors in United States, Investors in Israel, Investors in SF Bay Area (CA), Investors in Boston (MA), Investors in Boulder (CO)
Investors in Analytics (Series B), Investors in Sales & CRM (Seed), Investors in Analytics (Series A), Investors in Hardware (Seed), Investors in AI (Series B), Investors in Security (Seed), Investors in BioTech (Series B), Investors in Data Services (Series B), Investors in Cloud Infrastructure (Series B), Investors in Analytics (Seed), Investors in Cloud Infrastructure (Series A), Investors in Data Services (Seed), Investors in Hardware (Series B), Investors in Cloud Infrastructure (Seed), Investors in Hardware (Series A), Investors in Data Services (Series A), Investors in Enterprise (Series B), Investors in Sales & CRM (Series B), Investors in BioTech (Seed), Investors in Sales & CRM (Series A), Investors in Security (Series B), Investors in Security (Series A), Investors in AI (Seed), Investors in BioTech (Series A), Investors in AI (Seed), Investors in AI (Seed), Investors in AI (Seed), Investors in AI (Seed), Investors in AI (Seed), Investors in Analytics (Seed), Investors in AI (Series A), Investors in Analytics (Seed), Investors in Analytics (Seed), Investors in Analytics (Seed), Investors in Analytics (Seed), Investors in AI (Seed), Investors in Analytics (Seed), Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in AI (Seed), Investors in SaaS (Series B), Investors in BioTech (Seed), Investors in Israel (Other Lists), Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in Cloud Infrastructure (Seed), Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in Analytics (Seed), Investors in Cloud Infrastructure (Seed), Investors in Cloud Infrastructure (Seed), Investors in Cloud Infrastructure (Seed), Investors in Cloud Infrastructure (Seed), Investors in Data Services (Seed), Investors in Cloud Infrastructure (Seed), Investors in Analytics (Seed), Investors in Data Services (Seed), Investors in Data Services (Seed), Investors in Data Services (Seed), Investors in Data Services (Seed), Investors in Los Angeles / Southern California (Other Lists), Investors in Cloud Infrastructure (Seed), Investors in Data Services (Seed), Investors in Enterprise (Seed), Investors in BioTech (Seed), Investors in Data Services (Seed), Investors in Enterprise (Seed), Investors in Enterprise (Seed), Investors in Enterprise (Seed), Investors in Enterprise (Seed), Investors in Enterprise (Series A), Investors in Data Services (Seed), Investors in Enterprise (Seed), Investors in Hardware (Seed), Investors in Hardware (Seed), Investors in Hardware (Seed), Investors in Hardware (Seed), Investors in Hardware (Seed), Investors in Hardware (Seed), Investors in Hardware (Seed), Investors in New York City (Other Lists), Investors in Enterprise (Seed), Investors in Sales & CRM (Seed), Investors in SaaS (Seed), Investors in SaaS (Seed), Investors in Sales & CRM (Seed), Investors in Sales & CRM (Seed), Investors in Sales & CRM (Seed), Investors in SaaS (Seed), Investors in Hardware (Seed), Investors in SaaS (Seed), Investors in Security (Seed), Investors in Sales & CRM (Seed), Investors in SaaS (Seed), Investors in Security (Seed), Investors in Security (Seed), Investors in SaaS (Seed), Investors in Security (Seed), Investors in Sales & CRM (Seed), Investors in Security (Seed), Investors in Security (Seed), Investors in SaaS (Seed), Investors in Sales & CRM (Seed), Investors in SaaS (Seed), Investors in BioTech (Series A), Investors in AI (Series A), Investors in Security (Seed), Investors in AI (Series A), Investors in Analytics (Series A), Investors in AI (Series A), Investors in Sales & CRM (Seed), Investors in BioTech (Series A), Investors in AI (Series A), Investors in BioTech (Series A), Investors in Analytics (Series A), Investors in Analytics (Series A), Investors in BioTech (Series A), Investors in Analytics (Series A), Investors in Analytics (Series A), Investors in Analytics (Series A), Investors in San Francisco Bay Area (Other Lists), Investors in AI (Series A), Investors in AI (Series A), Investors in BioTech (Series A), Investors in BioTech (Series A), Investors in Analytics (Series A), Investors in Analytics (Series A), Investors in AI (Series A), Investors in Cloud Infrastructure (Series A), Investors in Cloud Infrastructure (Series A), Investors in Cloud Infrastructure (Series A), Investors in Cloud Infrastructure (Series A), Investors in Cloud Infrastructure (Series A), Investors in BioTech (Series A), Investors in Data Services (Series A), Investors in Cloud Infrastructure (Series A), Investors in Data Services (Series A), Investors in Data Services (Series A), Investors in Data Services (Series A), Investors in Data Services (Series A), Investors in Enterprise (Series A), Investors in Cloud Infrastructure (Series A), Investors in Data Services (Series A), Investors in Enterprise (Series A), Investors in Enterprise (Series A), Investors in Security (Seed), Investors in AI (Series A), Investors in Enterprise (Series A), Investors in BioTech (Series A), Investors in Data Services (Series A), Investors in Enterprise (Series A), Investors in Enterprise (Series A), Investors in Cloud Infrastructure (Series A), Investors in Data Services (Series A), Investors in Hardware (Series A), Investors in Hardware (Series A), Investors in Hardware (Series A), Investors in Enterprise (Series A), Investors in Hardware (Series A), Investors in Hardware (Series A), Investors in Hardware (Series A), Investors in Hardware (Series A), Investors in Hardware (Series A), Investors in Enterprise (Series A), Investors in SaaS (Series A), Investors in Sales & CRM (Series A), Investors in Sales & CRM (Series A), Investors in SaaS (Series A), Investors in Sales & CRM (Series A), Investors in SaaS (Series A), Investors in Security (Series A), Investors in Sales & CRM (Series A), Investors in SaaS (Series A), Investors in SaaS (Series A), Investors in Sales & CRM (Series A), Investors in SaaS (Series A), Investors in Security (Series A), Investors in Sales & CRM (Series A), Investors in SaaS (Series A), Investors in Security (Series A), Investors in Security (Series A), Investors in Sales & CRM (Series A), Investors in Analytics (Series B), Investors in Security (Series A), Investors in Security (Series A), Investors in AI (Series B), Investors in AI (Series B), Investors in AI (Series B), Investors in Analytics (Series B), Investors in Analytics (Series B), Investors in BioTech (Series B), Investors in AI (Series B), Investors in SaaS (Series A), Investors in Analytics (Series B), Investors in BioTech (Series B), Investors in Security (Series A), Investors in Sales & CRM (Series A), Investors in BioTech (Series B), Investors in AI (Series B), Investors in AI (Series B), Investors in BioTech (Series B), Investors in Analytics (Series B), Investors in Analytics (Series B), Investors in BioTech (Series B), Investors in BioTech (Series B), Investors in Cloud Infrastructure (Series B), Investors in Cloud Infrastructure (Series B), Investors in Cloud Infrastructure (Series B), Investors in AI (Series B), Investors in Data Services (Series B), Investors in Cloud Infrastructure (Series B), Investors in Analytics (Series B), Investors in Data Services (Series B), Investors in Cloud Infrastructure (Series B), Investors in Cloud Infrastructure (Series B), Investors in Data Services (Series B), Investors in BioTech (Series B), Investors in Hardware (Series B), Investors in Hardware (Series B), Investors in Data Services (Series B), Investors in Data Services (Series B), Investors in Hardware (Series B), Investors in Enterprise (Series B), Investors in Security (Series A), Investors in Enterprise (Series B), Investors in Data Services (Series B), Investors in Cloud Infrastructure (Series B), Investors in Analytics (Series B), Investors in AI (Series B), Investors in Enterprise (Series B), Investors in Enterprise (Series B), Investors in Enterprise (Series B), Investors in Hardware (Series B), Investors in BioTech (Series B), Investors in Data Services (Series B), Investors in Data Services (Series B), Investors in Enterprise (Series B), Investors in Hardware (Series B), Investors in Hardware (Series B), Investors in Cloud Infrastructure (Series B), Investors in Hardware (Series B), Investors in Enterprise (Series B), Investors in Enterprise (Series B), Investors in Hardware (Series B), Investors in SaaS (Series B), Investors in SaaS (Series B), Investors in SaaS (Series B), Investors in Sales & CRM (Series B), Investors in SaaS (Series B), Investors in Sales & CRM (Series B), Investors in Sales & CRM (Series B), Investors in Security (Series B), Investors in Security (Series B), Investors in SaaS (Series B), Investors in Security (Series B), Investors in Sales & CRM (Series B), Investors in Sales & CRM (Series B), Investors in Security (Series B), Investors in Sales & CRM (Series B), Investors in SaaS (Series B), Investors in Sales & CRM (Series B), Investors in Sales & CRM (Series B), Investors in Security (Series B), Investors in Security (Series B), Investors in SaaS (Series B), Investors in Security (Series B), Investors in SaaS (Series B), Investors in Colorado / Utah (Other Lists), Investors in Canada (Other Lists), Investors in Austin (Other Lists), Investors in Security (Series B), Investors in Boston / New England (Other Lists), Investors in LatAm (Latin America) (Other Lists), Investors in Cloud Infrastructure (Seed), Investors in SaaS (Series A), Investors in Enterprise (Seed), Investors in AI (Seed), Investors in SaaS (Seed), Investors in Enterprise (Seed)
Photo of Xinhong Lim, Managing Director at Vickers Venture Partners
Xinhong Lim
Vickers Venture Partners·Managing Director
Sweet spot: $5.0M
Range: $3.0M - $10.0M
Investors in Singapore, Investors in United Kingdom, Investors in United States, Investors in China, Investors in Indonesia, Investors in Canada
Investors in AI (Series B), Investors in ClimateTech/CleanTech (Series B), Investors in BioTech (Series B), Investors in EnergyTech (Series B), Investors in ClimateTech/CleanTech (Series A), Investors in EnergyTech (Series A), Investors in Medical Devices (Series B), Investors in Medical Devices (Series A), Investors in Material Science (Series B), Investors in Pharmaceuticals (Series B), Investors in Material Science (Series A), Investors in Chemicals (Series A), Investors in Chemicals (Series B), Investors in BioTech (Series A), Investors in Semiconductors (Series A), Investors in Semiconductors (Series B), Investors in Pharmaceuticals (Series A), Investors in Diverse Investors (Other Lists), Investors in AI (Series A), Investors in Investors who invested in female founders (Other Lists), Investors in Investors who invested in diverse founders (Other Lists), Investors in AI (Series A), Investors in BioTech (Series A), Investors in San Francisco Bay Area (Other Lists), Investors in ClimateTech/CleanTech (Series A), Investors in EnergyTech (Series A), Investors in Medical Devices (Series A), Investors in Semiconductors (Series A), Investors in Pharmaceuticals (Series A), Investors in Chemicals (Series A), Investors in AI (Series B), Investors in Material Science (Series A), Investors in BioTech (Series B), Investors in ClimateTech/CleanTech (Series B), Investors in EnergyTech (Series B), Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series B), Investors in Material Science (Series B), Investors in Semiconductors (Series B), Investors in Chemicals (Series B), Investors in Canada (Other Lists), Investors in Therapeutics (Series A), Investors in Therapeutics (Series A), Investors in Therapeutics (Series B), Investors in Therapeutics (Series B)
Photo of Ed Phillips, Partner at Future Planet Capital
Ed Phillips
Sweet spot: $750K
Range: $300K - $2.0M
Investors in United Kingdom, Investors in California, Investors in London, Investors in Israel, Investors in Canada, Investors in Boston (MA), Investors in New York
Investors in AgTech (Series B), Investors in Web3/Blockchain (Series B), Investors in AgTech (Series A), Investors in AI (Series B), Investors in ClimateTech/CleanTech (Series B), Investors in BioTech (Series B), Investors in AgTech (Seed), Investors in ClimateTech/CleanTech (Series A), Investors in ClimateTech/CleanTech (Seed), Investors in Web3/Blockchain (Seed), Investors in Enterprise (Series B), Investors in Web3/Blockchain (Series A), Investors in BioTech (Seed), Investors in AgTech (Seed), Investors in BioTech (Series A), Investors in AgTech (Seed), Investors in AgTech (Seed), Investors in AI (Seed), Investors in AgTech (Seed), Investors in AI (Seed), Investors in AI (Seed), Investors in AI (Seed), Investors in Investors who invested in female founders (Other Lists), Investors in Israel (Other Lists), Investors in BioTech (Seed), Investors in AI (Seed), Investors in AI (Series A), Investors in Web3/Blockchain (Seed), Investors in Investors who invested in diverse founders (Other Lists), Investors in Web3/Blockchain (Seed), Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in Web3/Blockchain (Seed), Investors in Web3/Blockchain (Seed), Investors in ClimateTech/CleanTech (Seed), Investors in ClimateTech/CleanTech (Seed), Investors in ClimateTech/CleanTech (Seed), Investors in ClimateTech/CleanTech (Seed), Investors in Enterprise (Seed), Investors in Enterprise (Seed), Investors in Enterprise (Seed), Investors in Enterprise (Seed), Investors in Enterprise (Series A), Investors in AgTech (Series A), Investors in AI (Series A), Investors in AgTech (Series A), Investors in AgTech (Series A), Investors in BioTech (Series A), Investors in Web3/Blockchain (Series A), Investors in AI (Series A), Investors in AgTech (Series A), Investors in AI (Series A), Investors in BioTech (Series A), Investors in AI (Series A), Investors in Web3/Blockchain (Series A), Investors in BioTech (Series A), Investors in Web3/Blockchain (Series A), Investors in BioTech (Series A), Investors in ClimateTech/CleanTech (Series A), Investors in Web3/Blockchain (Series A), Investors in ClimateTech/CleanTech (Series A), Investors in ClimateTech/CleanTech (Series A), Investors in ClimateTech/CleanTech (Series A), Investors in Enterprise (Series A), Investors in Enterprise (Series A), Investors in Enterprise (Series A), Investors in Enterprise (Series A), Investors in AgTech (Series B), Investors in AI (Series B), Investors in AgTech (Series B), Investors in AI (Series B), Investors in BioTech (Series B), Investors in AI (Series B), Investors in BioTech (Series B), Investors in BioTech (Series B), Investors in AI (Series B), Investors in Web3/Blockchain (Series B), Investors in AgTech (Series B), Investors in AgTech (Series B), Investors in Web3/Blockchain (Series B), Investors in Web3/Blockchain (Series B), Investors in BioTech (Series B), Investors in ClimateTech/CleanTech (Series B), Investors in ClimateTech/CleanTech (Series B), Investors in ClimateTech/CleanTech (Series B), Investors in Web3/Blockchain (Series B), Investors in ClimateTech/CleanTech (Series B), Investors in Enterprise (Series B), Investors in Enterprise (Series B), Investors in Enterprise (Series B), Investors in Enterprise (Series B), Investors in AutoTech (Series B), Investors in AutoTech (Seed), Investors in AutoTech (Series B), Investors in AutoTech (Series B), Investors in AutoTech (Series B), Investors in AutoTech (Series A), Investors in AutoTech (Seed), Investors in AutoTech (Series A), Investors in AutoTech (Series A), Investors in Canada (Other Lists), Investors in AutoTech (Series A), Investors in AutoTech (Seed), Investors in AutoTech (Seed), Investors in AutoTech (Series A), Investors in AutoTech (Series B), Investors in AutoTech (Seed), Investors in London (Other Lists), Investors in Boston / New England (Other Lists), Investors in DeepTech (Series B), Investors in DeepTech (Seed), Investors in DeepTech (Seed), Investors in DeepTech (Seed), Investors in DeepTech (Series B), Investors in DeepTech (Series A), Investors in DeepTech (Series A), Investors in DeepTech (Series B), Investors in DeepTech (Series B), Investors in DeepTech (Series B), Investors in DeepTech (Seed), Investors in DeepTech (Series A), Investors in DeepTech (Seed), Investors in DeepTech (Series A), Investors in DeepTech (Series A), Investors in Supply Chain Tech (Series B), Investors in Supply Chain Tech (Seed), Investors in Supply Chain Tech (Seed), Investors in Smart Cities/UrbanTech (Series B), Investors in Supply Chain Tech (Seed), Investors in Smart Cities/UrbanTech (Series A), Investors in Smart Cities/UrbanTech (Series A), Investors in Supply Chain Tech (Series B), Investors in Smart Cities/UrbanTech (Series B), Investors in Smart Cities/UrbanTech (Series A), Investors in Smart Cities/UrbanTech (Series A), Investors in Smart Cities/UrbanTech (Seed), Investors in Supply Chain Tech (Seed), Investors in Supply Chain Tech (Series A), Investors in Smart Cities/UrbanTech (Seed), Investors in Supply Chain Tech (Series B), Investors in Smart Cities/UrbanTech (Series B), Investors in Supply Chain Tech (Series A), Investors in Smart Cities/UrbanTech (Series B), Investors in Supply Chain Tech (Series A), Investors in Smart Cities/UrbanTech (Seed), Investors in Supply Chain Tech (Series B), Investors in Smart Cities/UrbanTech (Seed), Investors in Supply Chain Tech (Series A), Investors in Smart Cities/UrbanTech (Series A), Investors in Smart Cities/UrbanTech (Series B), Investors in Supply Chain Tech (Series A), Investors in Smart Cities/UrbanTech (Seed), Investors in Supply Chain Tech (Series B), Investors in Supply Chain Tech (Seed), Investors in Enterprise (Seed)
Photo of Daniella Kranjac, General Partner at AVANT BIO
Daniella Kranjac
AVANT BIO·General Partner
Sweet spot: $5.0M
Range: $3.0M - $10.0M
Investors in Switzerland, Investors in United Kingdom, Investors in Europe, Investors in Canada, Investors in United States
Investors in Consumer Health (Series B), Investors in BioTech (Series B), Investors in Consumer Health (Series A), Investors in Investors who invested in diverse founders (Other Lists), Investors in Health & Hospital Services (Series A), Investors in Female Investors (Other Lists), Investors in Diverse Investors (Other Lists), Investors in Consumer Health (Seed), Investors in BioTech (Series A), Investors in Digital Health (Series A), Investors in Health IT (Series B), Investors in Health & Hospital Services (Series B), Investors in Consumer Health (Seed), Investors in Digital Health (Seed), Investors in Investors who were founders (Other Lists), Investors in BioTech (Seed), Investors in Investors who invested in female founders (Other Lists), Investors in Consumer Health (Series A), Investors in Health & Hospital Services (Seed), Investors in New York City (Other Lists), Investors in Health IT (Series A), Investors in Canada (Other Lists), Investors in Health IT (Seed), Investors in Health & Hospital Services (Seed), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series A), Investors in Health & Hospital Services (Series B), Investors in BioTech (Series B), Investors in Consumer Health (Series B), Investors in Health IT (Series B), Investors in Digital Health (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Series B), Investors in Digital Health (Seed), Investors in Health IT (Series A), Investors in BioTech (Seed), Investors in Health IT (Seed)
Photo of Alex Brufsky, Partner at 1435 Capital SLLC
Alex Brufsky
Sweet spot: $1M
Range: $250K - $10.0M
Investors in Canada, Investors in United States
Investors in Analytics (Series B), Investors in AgTech (Series B), Investors in AR/VR (Series B), Investors in AR/VR (Seed), Investors in AI (Series B), Investors in Payments (Seed), Investors in ClimateTech/CleanTech (Series B), Investors in BioTech (Series B), Investors in AgTech (Seed), Investors in Analytics (Seed), Investors in Payments (Series B), Investors in IoT (Seed), Investors in ClimateTech/CleanTech (Seed), Investors in IoT (Series B), Investors in BioTech (Seed), Investors in FinTech (Series B), Investors in AgTech (Seed), Investors in AR/VR (Seed), Investors in AI (Seed), Investors in Investors who invested in female founders (Other Lists), Investors in Investors who were founders (Other Lists), Investors in Analytics (Seed), Investors in AI (Seed), Investors in BioTech (Seed), Investors in Investors who invested in diverse founders (Other Lists), Investors in ClimateTech/CleanTech (Seed), Investors in FinTech (Seed), Investors in New York City (Other Lists), Investors in IoT (Seed), Investors in Payments (Seed), Investors in AI (Series B), Investors in BioTech (Series B), Investors in Analytics (Series B), Investors in AR/VR (Series B), Investors in AgTech (Series B), Investors in ClimateTech/CleanTech (Series B), Investors in FinTech (Series B), Investors in IoT (Series B), Investors in Payments (Series B), Investors in Canada (Other Lists), Investors in FinTech (Seed)
Photo of Ken Belotsky, Managing Partner at Negev Capital
Ken Belotsky
Negev Capital·Managing Partner
Sweet spot: $1M
Range: $500K - $3.0M
Investors in Australia, Investors in Israel, Investors in Europe, Investors in United Kingdom, Investors in Canada, Investors in United States
Investors in BioTech (Series B), Investors in BioTech (Seed), Investors in Israel (Other Lists), Investors in BioTech (Series A), Investors in BioTech (Series A), Investors in Investors who were founders (Other Lists), Investors in BioTech (Seed), Investors in BioTech (Series B), Investors in BioTech (Series A), Investors in Canada (Other Lists), Investors in BioTech (Series B), Investors in BioTech (Seed)